ABAX - ABAXIS, Inc.

. Currency in USD
Stock chart is not supported by your current browser
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
VolumeN/A
Avg. VolumeN/A
Market CapN/A
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Puppy Cube Officially Launched in US on Amazon
    PR Newswire2 months ago

    Puppy Cube Officially Launched in US on Amazon

    SAN FRANCISCO , May 5, 2019 /PRNewswire/ -- Recently, the interactive touchscreen projector Puppy Cube was launched on Amazon.com and shipped by Amazon, with a retail price of $999 . At present, the official ...

  • Moody's10 months ago

    Zoetis Inc. -- Moody's assigns Baa1 to Zoetis' notes offering

    Moody's Investors Service ("Moody's") assigned a Baa1 rating to the proposed senior unsecured notes offering of Zoetis Inc. ("Zoetis"). There are no changes to Zoetis' existing ratings including the Baa1 senior unsecured rating and the Prime-2 commercial paper rating. Proceeds from the notes offerings will be used to repay short term debt that was used in financing the acquisition of Abaxis, Inc. and for general corporate purposes.

  • See what the IHS Markit Score report has to say about Abaxis Inc.
    Markit11 months ago

    See what the IHS Markit Score report has to say about Abaxis Inc.

    Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on July 16. Index (PMI) data, output in the Healthcare sector is rising.

  • PR Newswire11 months ago

    Triumph Bancorp Set to Join S&P SmallCap 600

    NEW YORK , July 31, 2018 /PRNewswire/ -- Triumph Bancorp Inc. (NASD: TBK) will replace Abaxis Inc. (NASD: ABAX) in the S&P SmallCap 600 effective prior to the open of trading on Monday, August 6 . S&P ...

  • HRC vs. ABAX: Which Stock Is the Better Value Option?
    Zacks11 months ago

    HRC vs. ABAX: Which Stock Is the Better Value Option?

    HRC vs. ABAX: Which Stock Is the Better Value Option?

  • Is Abaxis (ABAX) Outperforming Other Medical Stocks This Year?
    Zacks11 months ago

    Is Abaxis (ABAX) Outperforming Other Medical Stocks This Year?

    Is (ABAX) Outperforming Other Medical Stocks This Year?

  • Abaxis (ABAX) and Zoetis Merger Deal Crosses HRS Hurdle
    Zacks11 months ago

    Abaxis (ABAX) and Zoetis Merger Deal Crosses HRS Hurdle

    With the adoption of Abaxis' (ABAX) point-of-care diagnostic instruments post acquisition, the combined entity's veterinary diagnostics category should grow faster than the animal health industry.

  • ACCESSWIRE11 months ago

    Wired News - Zoetis Announces HSR Clearance for Acquisition of Animal Health Company Abaxis

    LONDON, UK / ACCESSWIRE / July 10, 2018 / If you want access to our free research report on Zoetis Inc. (NYSE: ZTS), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=ZTS as the Company's latest news hit the wire. On July 06, 2018, the Company announced that it has completed the acquisition of Abaxis, Inc. (NASDAQ: ABAX), which is a leader in the development, manufacture, and marketing of diagnostic instruments for veterinary point-of-care services, for $83.00 per share in cash, or approximately $2.0 billion in total.

  • Top Ranked Momentum Stocks to Buy for July 9th
    Zacks11 months ago

    Top Ranked Momentum Stocks to Buy for July 9th

    Top Ranked Momentum Stocks to Buy for July 9th

  • Zoetis and Abaxis Announce Antitrust Clearance for Merger
    Market Realist11 months ago

    Zoetis and Abaxis Announce Antitrust Clearance for Merger

    On July 6, Zoetis (ZTS) and Abaxis (ABAX) announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.

  • Zoetis and Abaxis Announce HSR Clearance for Zoetis’ Acquisition of Abaxis
    Business Wirelast year

    Zoetis and Abaxis Announce HSR Clearance for Zoetis’ Acquisition of Abaxis

    Zoetis Inc. (ZTS) and Abaxis, Inc. (ABAX) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), in connection with Zoetis’ previously-announced acquisition of Abaxis for US $83.00 per share in cash, or approximately $2.0 billion in aggregate. The expiration of the waiting period under the HSR Act satisfies one of the conditions necessary for the consummation of the transaction. The transaction is subject to other customary closing conditions, including the approval of Abaxis shareholders.

  • Here's Why You Should Add Abaxis (ABAX) to Your Portfolio
    Zackslast year

    Here's Why You Should Add Abaxis (ABAX) to Your Portfolio

    We are upbeat about Abaxis' (ABAX) solid consumable and instrument sales growth along with strength in the medical and veterinary market segments.

  • Cardiovascular Systems (CSII) in Focus: Stock Moves 7.7% Higher
    Zackslast year

    Cardiovascular Systems (CSII) in Focus: Stock Moves 7.7% Higher

    Cardiovascular Systems (CSII) was a big mover last session, as the company saw its shares rise nearly 8% on the day.